title: [Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol].
authors.affiliation: Fundación Jiménez Díaz, Servicio de Pediatría, Madrid.
authors.forename: M
authors.initials: M
authors.lastname: Bernacer
authors.forename: J
authors.initials: J
authors.lastname: Aracil
authors.forename: T
authors.initials: T
authors.lastname: Contra
authors.forename: C
authors.initials: C
authors.lastname: Gil
authors.forename: J
authors.initials: J
authors.lastname: López
authors.forename: B
authors.initials: B
authors.lastname: López-Ibor
authors.forename: N
authors.initials: N
authors.lastname: Martín
authors.forename: C
authors.initials: C
authors.lastname: Melero
authors.forename: F
authors.initials: F
authors.lastname: Valverde
authors.forename: C
authors.initials: C
authors.lastname: Vecilla
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Nuestra experiencia en el tratamiento de las leucemias agudas linfoblásticas (LAL) de riesgo con el protocolo terapéutico BFM-83.